Morgan Richard, Pandha Hardev S
Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, Bradford, BD7 1DP, UK.
Faculty of Health and Medical Sciences, University of Surrey, Guildford, GU2 7XH, UK.
Cancers (Basel). 2020 Feb 13;12(2):431. doi: 10.3390/cancers12020431.
PBX3 is a homeodomain-containing transcription factor of the pre-B cell leukemia (PBX) family, members of which have extensive roles in early development and some adult processes. A number of features distinguish PBX3 from other PBX proteins, including the ability to form specific and stable interactions with DNA in the absence of cofactors. PBX3 has frequently been reported as having a role in the development and maintenance of a malignant phenotype, and high levels of PBX3 tumor expression have been linked to shorter overall survival in cancer. In this review we consider the similarities and differences in the function of PBX3 in different cancer types and draw together the core signaling pathways involved to help provide a better insight into its potential as a therapeutic target.
PBX3是前B细胞白血病(PBX)家族中一种含同源结构域的转录因子,该家族成员在早期发育和一些成年期过程中发挥着广泛作用。PBX3具有一些区别于其他PBX蛋白的特征,包括在没有辅助因子的情况下与DNA形成特异性稳定相互作用的能力。PBX3经常被报道在恶性表型的发生和维持中起作用,并且PBX3在肿瘤中的高表达与癌症患者较短的总生存期相关。在本综述中,我们探讨了PBX3在不同癌症类型中的功能异同,并汇总了相关的核心信号通路,以更好地洞察其作为治疗靶点的潜力。